- CDC now recommends that individuals aged 65 years and older, residents in long-term care settings, and people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 Vaccine at least 6 months after completing their Pfizer-BioNTech primary series. Select individuals aged 18-49 are also eligible to receive a booster shot, visit our FAQ’s for more information.
- Select immunocompromised individuals are eligible for a 3rd dose of Pfizer or Moderna COVID-19 vaccine. Get CDC details. Walk-in or schedule your appointment today.
- Second dose shots: You can walk-in or schedule an appointment for your second dose Moderna or Pfizer vaccine even if you received your first dose Moderna or Pfizer vaccine at a different location.
Now offering the free* COVID-19 vaccine. Walk-ins are welcomed!
$20 in FREE Groceries! Get a $10 Harveys Coupon when get your COVID-19 shot + a $10 Harveys Coupon with any other vaccine received on the same day! Click here for details.
Harveys pharmacies are now able to administer the COVID-19 vaccine. Our pharmacists are experienced in safely providing immunizations, such as flu, shingles and pneumonia. As always, we follow all CDC and state recommended guidelines. Schedule your appointment to save time. Walk-ins are always welcome! To save time, download our consent form now
- *No cost through most insurances or through federal program if not insured. Availability can change quickly based on demand; we understand this might be frustrating. If there are no available appointments at the location you selected, you may choose a nearby location or check back frequently for the next opportunity to schedule your appointment.
COVID Vaccines and Doses
||Adults 18 and older under EUA||https://rb.gy/khgiyi|
The FDA has granted full approval for ages 16+. Emergency use authorization (EUA) continues for ages 12 to 15.
CDC now recommends that the following individuals should receive a booster dose:
|Johnson & Johnson (Janssen)||
||Adults 18 and older under EUA||https://rb.gy/7f2yen|
Promote health and wellness in your community or workplace
We're here to support your organization's on‐site clinic needs. We would be happy to conduct an on‐site vaccine clinic for your organization or community.
Clinic facts and requirements
Ready to request an off-site vaccine clinic for your business or organization?
Additional COVID-19 resources
Stay up-to-date with the latest information from the CDC
More information on the COVID-19 vaccine
Find the most up-to-date information from your state’s health department
Harveys vaccine FAQs
- People 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series;
- People aged 50 to 64 with certain underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series;
- People 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks; and
- People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
CDC’s independent Advisory Committee on Immunization Practices (ACIP) recommended certain populations receive a booster shot of Pfizer-BioNTech’s COVID-19 Vaccine at least six months after the completion of their Pfizer vaccine primary series. For more information please visit https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html.
Currently, the Pfizer-BioNTech booster authorization only applies to people whose primary series was Pfizer-BioNTech vaccine. People in the recommended groups who got the Moderna or J&J/Janssen vaccine will likely need a booster shot. More data on the effectiveness and safety of Moderna and J&J/Janssen booster shots are expected in the coming weeks.
Certain individuals who are moderately to severely immunocompromised may not build enough (or any) protection when they first get a vaccination. When this happens, getting another dose of the vaccine can sometimes help them build more protection against the disease. CDC recommends moderately to severely immunocompromised people consider receiving an additional (third) dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) at least 28 days after the completion of the initial 2-dose mRNA COVID-19 vaccine series.
In contrast, a “booster dose” refers to another dose of a vaccine that is given to someone who built enough protection after vaccination, but then that protection decreased over time (this is called waning immunity).
For many who have completed their primary series with Pfizer-BioNTech vaccine, the benefits of getting a booster shot outweigh the known and potential risks. So far, reactions reported after the third PfizerBioNTech shot were similar to that of the 2-shot primary series. Fatigue and pain at the injection site were the most commonly reported side effects, and overall, most side effects were mild to moderate. However, as with the 2-shot primary series, serious side effects are rare, but may occur.
You can walk-in or schedule an appointment for your second dose Moderna or Pfizer vaccine even if you received your first dose Moderna or Pfizer vaccine at a different location.
As of August 23, 2021, the FDA has issued full approval of the Pfizer-BioNTech vaccine for ages 16+. The FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines. Other COVID-19 vaccines are in development and will be reviewed by the FDA under EUA. Find the current status of the vaccine approvals and EUAs.
On August 12, the FDA authorized an additional vaccine dose for certain immunocompromised individuals as part of its Emergency Use Authorization (EUA) amendment. The amendment applies to the Pfizer-BioNTech COVID-19 vaccine for patients 12 years and older and the Moderna COVID-19 vaccine for patients 18 years and older. Due to insufficient data, the EUA amendment for an additional dose does not apply to the Johnson & Johnson (Janssen) COVID-19 vaccine or to individuals who received the Johnson & Johnson (Janssen) COVID-19 vaccine as a primary series.
Yes, the additional dose is available at no cost to any eligible patient either through insurance or a federal program for the uninsured.
Yes. If you received your first dose Moderna or Pfizer vaccine elsewhere, you may still walk-in or schedule an appointment to receive your second dose vaccine at your local Harveys pharmacy.
The goal for Operation Warp Speed is to deliver safe vaccines that work, with the first supply becoming available before the end of 2020.
Currently, three vaccines are authorized and recommended to prevent COVID-19 in the United States. To help guide decisions about how to distribute limited initial supplies of COVID-19 vaccine, the CDC and the Advisory Committee on Immunization Practices have published recommendations for who should be vaccinated first. Supplies will increase over time. The goal is for everyone to be able to easily get a COVID-19 vaccine as soon as large quantities are available. However, a COVID-19 vaccine may not be available for young children until more studies are completed.
The U.S. vaccine safety system ensures that all vaccines are as safe as possible. Safety is a top priority while federal partners work to make this and other COVID-19 vaccines available.
The CDC and FDA encourage the public to report possible side effects (called adverse events) to the Vaccine Adverse Event Reporting System (VAERS). This national system collects these data to look for adverse events that are unexpected, appear to happen more often than expected, or have unusual patterns of occurrence. Learn about the difference between a vaccine side effect and an adverse event. Reports to VAERS help the CDC monitor the safety of vaccines. Safety is a top priority. Healthcare providers will be required to report certain adverse events following vaccination to VAERS. Healthcare providers also have to adhere to any revised safety reporting requirements according to FDA’s conditions of authorized use throughout the duration of any Emergency Use Authorization; these requirements would be posted on FDA’s website.
The CDC is also implementing a new smartphone-based tool called v-safe to check-in on people’s health after they receive a COVID-19 vaccine. When you receive your vaccine, you should also receive a v-safe information sheet telling you how to enroll in v-safe. If you enroll, you will receive regular text messages directing you to surveys where you can report any problems or adverse reactions you have after receiving a COVID-19 vaccine.
COVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the illness. Different types of vaccines work in different ways to offer protection, but with all types of vaccines, the body is left with a supply of “memory” T-lymphocytes as well as B-lymphocytes that will remember how to fight that virus in the future. It typically takes a few weeks for the body to produce T-lymphocytes and B-lymphocytes after vaccination. Therefore, it is possible that a person could be infected with the virus that causes COVID-19 just before or just after vaccination and then get sick because the vaccine did not have enough time to provide protection. Sometimes after vaccination, the process of building immunity can cause symptoms, such as fever. These symptoms are normal and are a sign that the body is building immunity.
Vaccine doses will be given to the American people at no cost. The Federal Bureau of Investigation (FBI), Department of Health and Human Services Office of Inspector General (HHS-OIG), and Centers for Medicare & Medicaid Services (CMS) are warning the public about several emerging fraud schemes related to COVID-19 vaccines. If you believe you have been the victim of a COVID-19 fraud, immediately report it to the FBI (ic3.gov, tips.fbi.gov, or 1-800-CALL-FBI) or HHS OIG (tips.hhs.gov or 1-800-HHS-TIPS)
Yes, walk-ups are welcome.
Find your nearest pharmacy.
Looking for a location near you? Find a Harveys pharmacy in your area.
- All Florida residents ages 12 and older are now eligible to receive the COVID-19 vaccine. The Pfizer vaccine is authorized for persons 12 and up. The Moderna and Janssen (Johnson and Johnson) vaccines are authorized for persons age 18 and up.
- All Georgia residents ages 12 and older are now eligible to receive the COVID-19 vaccine. The Pfizer vaccine is authorized for persons 12 and up. The Moderna and Janssen (Johnson and Johnson) vaccines are authorized for persons age 18 and up.